JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EPSTEIN, R. A.
Right arrow Articles by JACKSON, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by EPSTEIN, R. A.
Right arrow Articles by JACKSON, S. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 170, Issue 1, 153-156, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF HEXAFLUORENIUM ON THE NEUROMUSCULAR REFRACTORY PERIOD OF ANESTHETIZED MAN

RALPH A. EPSTEIN 1 and STEPHEN H. JACKSON 1

1 Anesthesiology Department, Clinical Center, National Institu Ies of health, Bethesda, Maryland

In anesthetized man, hexafluorenium. in a dose of 0.4 mg/kg i.v., did not cause neuromuscular blockade. It did however, decrease the neuromuscular refractory period, as determined by observation of both the tension and compound action potential of the indirectly stimulated adductor pollicis muscle. This is evidence for a direct effect of hexafluorenium at the neuromuscular junction. This effect on the neuromuscular refractony period is ol) posite to that of inhibitors of true cholinesterase, such as neostigmine and edrophonium.

Submitted on April 28, 1969
Accepted on August 3, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.